← Leaderboards
Roger M Kurlan
University Of Rochester
$13,810,390
Attributed
$13,810,390
Total exposure
18
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$13,810,390 · 18
By mechanism
U01$7,255,374 · 1
R01$6,328,979 · 3
M01$226,037 · 14
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Justin T Baker$4,497,285
- Irene H Richard$4,554,718
- Kenneth R Conner$6,670,856
- Danhong Wang$1,967,644
- Szilvia Arany$638,095
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationParkinson'S DiseaseAntiparkinson DrugsBrain Disorder ChemotherapyDrug Screening /EvaluationTourette'S SyndromeCombination ChemotherapyDopamine AgonistsLongitudinal Human StudyMental Disorder ChemotherapyAnxietyComorbidityPatient Oriented ResearchAttention Deficit DisorderClinical TrialsAdolescence (12-20)CatalogsCatalogingNervous System Disorder ChemotherapyNeuropsychological TestsCollectionDrug Adverse Effect
Grant awards (42)
Parkinson's Disease Data Organizing Center$1,137,270
U01 · FY2010 · NS · contact PI
Parkinson's Disease Data Organizing Center$1,207,438
U01 · FY2009 · NS · contact PI
Parkinson's Disease Data Organizing Center$1,211,691
U01 · FY2008 · NS · contact PI
Parkinson's Disease Data Organizing Center$1,125,810
U01 · FY2007 · NS · contact PI
Parkinson's Disease Data Organizing Center$65,000
U01 · FY2007 · NS · contact PI
Parkinson's Disease Data Organizing Center$1,220,478
U01 · FY2005 · NS
Parkinson's Disease Data Organizing Center$287,687
U01 · FY2005 · NS
Parkinson's Disease Data Organizing Center$1,000,000
U01 · FY2004 · NS
Treating Agitation/Psychosis in Dementia/Parkinsonism$818,387
R01 · FY2004 · AG
PANDAS and Strep Infection: Are they Linked?$808,294
R01 · FY2004 · NS
Treating Agitation/Psychosis in Dementia/Parkinsonism$958,094
R01 · FY2003 · AG
PANDAS and Strep Infection: Are they Linked?$778,132
R01 · FY2003 · NS
Treating Agitation/Psychosis in Dementia/Parkinsonism$1,229,242
R01 · FY2002 · AG
PANDAS and Strep Infection: Are they Linked?$779,155
R01 · FY2002 · NS
PARKINSON'S DISEASE COLLABORATIVE STUDY OF GENETIC LINKAGE$0
M01 · FY2002 · RR
LONG-TERM SAFETY STUDY OF PRAMIPEXOLE IN EARLY PARKINSON'S DISEASE$0
M01 · FY2002 · RR
CALM-PD PARALLEL GROUP DP, STUDY OF PRAMIPEXOLE AND CARBIDOPA-L IN PD$0
M01 · FY2002 · RR
EARLY VS LATE L DOPA IN PARKINSONS DISEASE (ELLDOPA)$0
M01 · FY2002 · RR
PATTERN OF INHERITANCE AND GENETIC LOCATION OF TOURETTE'S SYNDROME$0
M01 · FY2002 · RR
EFFECTS OF COENZYME Q10 IN EARLY PARKINSON'S DISEASE$0
M01 · FY2002 · RR
EFFICACY/SAFETY OF MECAMYLAMINE IN TOURETTE DISORDER$0
M01 · FY2002 · RR
LONG TERM SAFETY--ENTACAPONE IN PARKINSON'S DISEASE$0
M01 · FY2002 · RR
PANDAS and Strep Infection: Are they Linked?$860,898
R01 · FY2001 · NS
SELEGILINE TRANSDERMAL SYSTEM IN LEVADOPA/CARBIDOPA PARKINSON'S PATIENTS$19,613
M01 · FY2001 · RR
CALM-PD PARALLEL GROUP DP, STUDY OF PRAMIPEXOLE AND CARBIDOPA-L IN PD$19,613
M01 · FY2001 · RR
PSYCHOSIS AND CLOZAPINE IN PARKINSON'S DISEASE (PSYCLOPS)$19,613
M01 · FY2001 · RR
NORTH AMERICAN OPEN LABEL--ENTACAPONE IN PATIENTS WITH PARKINSON'S DISEASE$19,613
M01 · FY2001 · RR
LONG-TERM SAFETY STUDY OF PRAMIPEXOLE IN EARLY PARKINSON'S DISEASE$19,613
M01 · FY2001 · RR
TSA SIB-PAIR STUDY$19,613
M01 · FY2001 · RR
SAFETY, TOLERABILITY AND EFFICACY OF REMACEMIDE HYDROCHLORIDE IN PARKINSONS$19,613
M01 · FY2001 · RR
TREATMENT OF ADHD IN CHILDREN WITH TOURETTES SYNDROME$96,777
R01 · FY2000 · NS
LONG-TERM SAFETY STUDY OF PRAMIPEXOLE IN EARLY PARKINSON'S DISEASE$14,791
M01 · FY2000 · RR
SAFETY, TOLERABILITY AND EFFICACY OF REMACEMIDE HYDROCHLORIDE IN PARKINSONS$14,791
M01 · FY2000 · RR
CALM-PD PARALLEL GROUP DP, STUDY OF PRAMIPEXOLE AND CARBIDOPA-L IN PD$14,791
M01 · FY2000 · RR
EARLY VS LATE L DOPA IN PARKINSONS DISEASE (ELLDOPA)$14,791
M01 · FY2000 · RR
SELEGILINE TRANSDERMAL SYSTEM IN LEVADOPA/CARBIDOPA PARKINSON'S PATIENTS$14,791
M01 · FY2000 · RR
R, PILOT ASSESSMENT OF SE OF SELEGILINE TDS IN CHILDREN W/ AD/HD &TO$14,791
M01 · FY2000 · RR
PATTERN OF INHERITANCE AND GENETIC LOCATION OF TOURETTE'S SYNDROME$0
M01 · FY2000 · RR
LONG TERM SAFETY--ENTACAPONE IN PARKINSON'S DISEASE$0
M01 · FY2000 · RR
PARKINSON'S DISEASE COLLABORATIVE STUDY OF GENETIC LINKAGE$0
M01 · FY2000 · RR
EFFICACY/SAFETY OF MECAMYLAMINE IN TOURETTE DISORDER$0
M01 · FY2000 · RR
EFFECTS OF COENZYME Q10 IN EARLY PARKINSON'S DISEASE$0
M01 · FY2000 · RR